Kureha Kagaku Kogyo Kabushiki Kaisha

Yasuhiko Kobayashi

Takayoshi Fujii

Chikao Yoshikumi

Yuji Maeda

Kenichi Saito

Tadaaki Kato

Hideyuki Yamato

Fumio Hirose

Disclosed herein is a method for inhibiting the formation of urinary calculus by the administration of 24,25-dihydroxycholecarciferol.

Method for inhibiting the formation of urinary calculus utilizing

Disclosed herein is a pharmaceutical composition in dosage unit form, which comprises a dosage effective for treating nephritic disease of a compound of 24,25-dihydroxycholecalciferol as an active ingredient and a pharmaceutically acceptable carrier.

Antinephritic pharmaceutical composition containing 24,

Disclosed herein is a pharmaceutical composition in dosage unit form, which comprises a dosage effective for treating osteoporosis of a compound of 24,25-dihydroxycholecalciferol and a pharmaceutically acceptable carrier.

Antiosteoporotic pharmaceutical composition containing

Pharmaceutical composition in dosage unit form, comprising a therapeutically effective amount of 24,25-dihydroxycholecalciferol and a pharmaceutically acceptable carrier. The compound of 24,25-dihydroxycholecalciferol has anti-hypercalcemic activity, anti-ulcer activity, activity of preventing reduction of immunity, activity of controlling magnesium-metabolism, anti-hyperphosphatemic activity, activity of controlling blood sugar level and anti-tumor activity.

Growing community of inventors

Tokyo, Japan

Yasuhiko Kobayashi